Quelofy Technologies Private Limited: Enhancing Pressure Ulcer Prevention Through Intelligent Monitoring

Pressure ulcers, also known as decubitus ulcers or bedsores, represent a significant iatrogenic complication among hospitalized and immobile patients. They are associated with increased morbidity, secondary infections, prolonged hospitalization, and elevated healthcare costs. Despite established preventive protocols, including scheduled repositioning and skin inspections, incidence rates remain substantial, indicating a need for continuous monitoring and early detection solutions.

Quelofy Technologies Private Limited is a medtech and healthtech startup focused on addressing this clinical gap through technology-enabled, evidence-based pressure ulcer prevention.

Company Overview

Founded by Manoj and Keerthana, Quelofy Technologies develops scalable, workflow-compatible solutions to enhance patient safety. The company emphasizes early risk identification and proactive intervention to reduce pressure ulcer incidence, optimize caregiver efficiency, and improve clinical outcomes.

Preventix: Continuous Risk Monitoring and Early Intervention

Preventix is a next-generation pressure ulcer prevention platform designed for continuous assessment of pressure-related risk factors and early indicators of skin stress. The system provides objective data and real-time alerts to guide clinicians and caregivers in implementing timely interventions prior to ulcer formation or progression.

Preventix is clinically applicable in:

  • Acute care hospitals

  • Long-term care facilities

  • Rehabilitation centers

  • Elderly care environments

Patients with limited mobility, chronic conditions, or prolonged immobilization are primary candidates for Preventix monitoring.

Clinical Benefits

Preventix supports evidence-based prevention by:

  • Enabling real-time detection of pressure-related risk factors

  • Facilitating early preventive clinical interventions

  • Reducing dependency on rigid, manual repositioning schedules

  • Providing data-driven guidance for patient positioning and care

  • Improving patient comfort, safety, and continuity of care

The platform integrates with standard nursing workflows and institutional prevention protocols, enhancing consistency in care delivery.

Implementation and Scalability

Designed for practical adoption, Preventix is affordable, intuitive, and compatible with existing clinical infrastructure. Its deployment is feasible across diverse healthcare settings, including resource-constrained environments, ensuring broad accessibility of advanced preventive technology.

Contribution to Patient Safety

By enabling continuous monitoring, early detection, and data-informed intervention, Quelofy Technologies contributes to reducing preventable complications associated with pressure ulcers. Preventix aligns with institutional and national patient safety objectives, supporting improved clinical outcomes and adherence to quality-of-care standards.

Company Information

  • Company Name: Quelofy Technologies Private Limited

  • Founders: Manoj and Keerthana

  • Date of Incorporation: October 15, 2025

  • Registered Office:
    No. 171, OM Sai Nagar, Kalluballu, Jigani,
    Bangalore, Karnataka – 560105

  • Website: www.quelofy.com

Leave a Reply

Your email address will not be published. Required fields are marked *